Russell Investments Group, Ltd. Chembio Diagnostics, Inc. Transaction History

Russell Investments Group, Ltd.

  • $60.3 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 29, 2020
BUY
$3.94 - $5.76 $25,791 - $37,704
6,546 Added 36.27%
24,595 $111,000
Q3 2019

Nov 01, 2019
BUY
$4.84 - $7.25 $87,357 - $130,855
18,049 New
18,049 $110,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email